Alexion Pharmaceuticals, Inc. EBITDA Margin 2010-2021 | ALXN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Alexion Pharmaceuticals, Inc. (ALXN) over the last 10 years. The current EBITDA margin for Alexion Pharmaceuticals, Inc. as of March 31, 2021 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2021-03-31 $6.26B $2.94B 46.97%
2020-12-31 $6.07B $3.02B 49.66%
2020-09-30 $5.86B $2.95B 50.32%
2020-06-30 $5.54B $2.81B 50.80%
2020-03-31 $5.30B $2.67B 50.41%
2019-12-31 $4.99B $2.50B 50.06%
2019-09-30 $4.74B $2.02B 42.70%
2019-06-30 $4.50B $1.86B 41.41%
2019-03-31 $4.34B $0.93B 21.52%
2018-12-31 $4.13B $0.69B 16.67%
2018-09-30 $3.91B $0.83B 21.13%
2018-06-30 $3.75B $0.52B 13.94%
2018-03-31 $3.61B $1.18B 32.69%
2017-12-31 $3.55B $1.12B 31.64%
2017-09-30 $3.47B $1.06B 30.49%
2017-06-30 $3.41B $1.18B 34.54%
2017-03-31 $3.25B $1.11B 34.21%
2016-12-31 $3.08B $1.06B 34.50%
2016-09-30 $2.95B $1.03B 34.73%
2016-06-30 $2.82B $0.95B 33.70%
2016-03-31 $2.71B $0.85B 31.35%
2015-12-31 $2.60B $0.70B 26.96%
2015-09-30 $2.50B $0.73B 29.17%
2015-06-30 $2.39B $0.78B 32.46%
2015-03-31 $2.27B $0.82B 36.13%
2014-12-31 $2.23B $0.93B 41.54%
2014-09-30 $2.08B $0.89B 42.97%
2014-06-30 $1.92B $0.79B 40.86%
2014-03-31 $1.78B $0.70B 39.12%
2013-12-31 $1.55B $0.59B 38.23%
2013-09-30 $1.43B $0.52B 36.64%
2013-06-30 $1.32B $0.56B 41.99%
2013-03-31 $1.23B $0.50B 40.76%
2012-12-31 $1.14B $0.45B 40.00%
2012-09-30 $1.04B $0.42B 40.31%
2012-06-30 $0.95B $0.32B 33.09%
2012-03-31 $0.86B $0.28B 32.44%
2011-12-31 $0.78B $0.25B 31.76%
2011-09-30 $0.71B $0.22B 30.48%
2011-06-30 $0.65B $0.19B 29.85%
2011-03-31 $0.59B $0.18B 30.00%
2010-12-31 $0.54B $0.17B 30.81%
2010-09-30 $0.50B $0.15B 29.18%
2010-06-30 $0.46B $0.13B 28.17%
2010-03-31 $0.42B $0.12B 27.36%
2009-12-31 $0.39B $0.10B 25.84%